MedPath

BROMELAIN 500 + PAPAIN AND GALACTOSIDASE

BROMELAIN 500 + PAPAIN AND GALACTOSIDASE

Discontinued
DIN Number

00849928

Drug Class

Human

Market Date

Oct 20, 1997

Company
HC

nu-life nutrition ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00849928
AIG Number0331851001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A09AA02 MULTIENZYMES (LIPASE, PROTEASE ETC)
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification56:16.00
Health Canada Classification

ACTIVE INGREDIENTS (3)

ALPHA-GALACTOSIDASEActive
Strength: 50 MG
Monograph: ALPHA-GALACTOSIDASE
BROMELAINActive
Strength: 250 MG
Monograph: BROMELAIN
PAPAINActive
Strength: 75 MG
Monograph: PAPAIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.